Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind very-low-dose parallel-controlled study of HC001 granules in children with acute watery diarrhea (damp-heat pattern)
CTR20221816Phase 2Completed
- Sponsor
- Houcheng Pharma
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of finerenone in acute watery diarrhea (2 arms), sponsored by Houcheng Pharma. Primary endpoints: Diarrhea efficacy, Time to onset of antidiarrheal effect and 2 more. Started Dec 2022; status: completed.
02
Drugs
finerenone
03
Conditions
acute watery diarrhea
Beyond the preview
Go deeper on CTR20221816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221816.